Norris Medicines Ltd Q2FY22 loss at Rs. 78.85 lakhs

The Board of Directors of NORRIS MEDICINES LTD., at its meeting held today have approved the unaudited Standalone financial results of the company for the period ended September 30, 2021.

For the quarter ended September 30, 2021(Q2 FY2022), the company's total income was ₹2.1991 crore, against ₹3.1653 crore in the corresponding quarter of the previous year (YoY) and ₹4.9097 crore in previous quarter (QoQ).

For the quarter ended September 30, 2021(Q2 FY2022), the company's net profit / (loss) was ₹-0.7885 crore, against ₹-1.2928 crore in the corresponding quarter of the previous year (YoY) and ₹-0.0549 crore in previous quarter (QoQ).

For the quarter ended September 30, 2021(Q2 FY2022), the company's Earnings Per Share (EPS) was ₹-0.79, against ₹-1.29 in the corresponding quarter of the previous year (YoY) and ₹-0.05 in previous quarter (QoQ).

Financials	Q2 FY2022	Q1 FY2022	QoQ % Change	Q2 FY2021	YoY % Change
Total Income	₹2.1991 crs	₹4.9097 crs	-55.21%	₹3.1653 crs	-30.52%
Net Profit	₹-0.7885 crs	₹-0.0549 crs	1,336.25%	₹-1.2928 crs	39.01 %
EPS	₹-0.79	₹-0.05	1,480.00%	₹-1.29	38.76%

For the 6 Months period ended September 30, 2021(Half Year Ended FY 2022), the company's total income was ₹7.1089 crore, against ₹5.0321 crore in the previous year (YoY) (Half Year Ended FY 2021).

The net profit / (loss) was at ₹-0.8434 crore for the 6 Months period ended September 30, 2021 (Half Year Ended FY 2022), compared to ₹-1.5455 crore in the previous year (YoY) (Half Year Ended FY 2021).

The Earnings Per Share stood at ₹-0.84 for the 6 Months period ended September 30, 2021 (Half Year Ended FY 2022), against ₹-1.55 in the previous year (YoY) (Half Year Ended FY 2021).

Financials	Half Year Ended FY2022	Half Year Ended FY2021	% Change
Total Income	₹7.1089 crs	₹5.0321 crs	41.27%
Net Profit	₹-0.8434 crs	₹-1.5455 crs	45.43%
EPS	₹-0.84	₹-1.55	45.81%

Shares of NORRIS MEDICINES LTD. was last trading in BSE at Rs. 10.80 as compared to the previous close of Rs. 11.00. The total number of shares traded during the day was 105 in over 6 trades.

The stock hit an intraday high of Rs. 11.45 and intraday low of 10.46. The net turnover during the day was Rs. 1122.00.

Source : Equity Bulls

Keywords

NorrisMedicines Q2FY22 H1FY22 ResultUpdate